UWM (UWMC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Oct, 2026Preliminary third-quarter estimates
Preliminary 3Q26 revenue of $800-$825 million, Adjusted EBITDA of $170-$190 million and net income of $205-$220 million.
Origination volume of $33.4 billion, including $22.8 billion purchase and $10.6 billion refinance; total gain margin ~124 bps.
Loan production income of $410-$420 million; operating expenses, excluding interest expense and servicing cost, of $375-$385 million.
Loan servicing income of $240-$250 million; servicing portfolio UPB of ~$270 billion at Sep. 30, with 5.97% weighted average coupon and ~40 bps servicing fee.
Sep. 30 Total Preferred and Common Equity of ~$2.8 billion; net non-funding debt to equity of 1.75x-1.80x.
2026 outlook and capital actions
Expected to originate ~8% of U.S. residential mortgage production in 2026 and end the year with $210-$230 billion of MSR portfolio UPB.
FY26 revenue estimated at $3.35-$3.50 billion.
Expected Q4 MSR sales of $70-$80 billion, with proceeds above $1.8 billion; MSR and rights-offering proceeds are intended to support ongoing non-funding debt paydown.
Closed a $1.65 billion Series A preferred investment from Oaktree and SFS Group on Aug. 5; launched a ~$400 million rights offering on Oct. 5, expiring Nov. 12.
Rights offering terms
Offering covers 200 million Class A shares at the greater of $2.00 or 85% of the 10-day VWAP ending three trading days before expiration; rights are transferable, with oversubscription available to fully exercising holders.
Mat Ishbia agreed to exercise rights for 408,131 personally held Class A shares; Oaktree may, but is not obligated to, backstop unsubscribed shares.
Oaktree may backstop in common stock or junior perpetual preferred stock with warrants; SFS Group is obligated to buy any remaining shares, ensuring at least $400 million gross proceeds.
SFS Group's backstop may also be in common stock or junior perpetual preferred stock with warrants; the preferred is subordinated to Series A and includes warrants equal to 20% of initial liquidation preference.
Based on the then-current share price, material subscriptions from outside investors appeared unlikely.
Latest events from UWM
- Q3 profit recovered, while lower originations and rate-sensitive valuations persisted.UWMC
Q3 2026 - Broker-channel growth and deleveraging underpin the 2030 plan.UWMC
Investor presentation - Q2 2026 saw $39.7B in originations, a $451.9M net loss, and a $1.65B capital infusion.UWMC
Q2 2026 - Q3 originations hit $41.7B; Adjusted EBITDA reached $211.1M as net income fell year over year.UWMC
Q3 2025 - Q2 delivered $39.7B in production and $314.5M in net income; Q3 margin guidance rose.UWMC
Q2 2025 - Q3 originations reached $39.5B as MSR valuation declines weighed on net income.UWMC
Q3 2024 - Production rose to $33.6B as net income reached $76.286M despite MSR fair-value pressure.UWMC
Q2 2024 - Q1 originations rose 17.1% to $32.4B, while MSR losses drove a $247M net loss.UWMC
Q1 2025 - Record $96.1B purchase production and $329.4M net income in 2024.UWMC
Q4 2024